European Journal of Pharmacology

Elsevier
Elsevier
ISSN: 00142999, 18790712

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
SCImago
Q1
WOS
Q1
Impact factor
4.2
SJR
1.055
CiteScore
9.0
Categories
Pharmacology
Areas
Pharmacology, Toxicology and Pharmaceutics
Years of issue
1967-2025
journal names
European Journal of Pharmacology
EUR J PHARMACOL
Publications
41 264
Citations
1 051 826
h-index
232
Top-3 citing journals
Brain Research
Brain Research (24961 citations)
Top-3 organizations
Karolinska Institute
Karolinska Institute (341 publications)
Utrecht University
Utrecht University (332 publications)
University of Melbourne
University of Melbourne (224 publications)
Top-3 countries
USA (7949 publications)
Japan (5014 publications)
China (4162 publications)

Most cited in 5 years

Found 
from chars
Publications found: 2872
Relationship between lipoprotein B and the severity of coronary microvascular dysfunction
Yang L., Zhang J., Han J., Jiang X.
Q3
Taylor & Francis
Clinical and Experimental Hypertension 2025 citations by CoLab: 0
Open Access
Open access
PDF
Safety and efficacy of extravascular renal denervation using HyperQure™ renal denervation system in short-term swine model of hypertension
Han J.H., Sharapatov Y., Do M., Kim S.Y., Han B., Choi E., Jeong C.W.
Q3
Taylor & Francis
Clinical and Experimental Hypertension 2025 citations by CoLab: 0
Open Access
Open access
PDF
High-salt diets provoke phosphorus absorption from the small intestine in mice
Yang M., You H., Ni L., Mao J., Chen J.
Q3
Taylor & Francis
Clinical and Experimental Hypertension 2025 citations by CoLab: 0
Open Access
Open access
PDF
Efficacy and safety of intensive blood pressure control in patients over 60 years: A systematic review and meta-analysis
Yang H., Xing H., Zou X., Jin M., Li Y., Xiao K., Cai L., Liu Y., Yang X.
Q3
Taylor & Francis
Clinical and Experimental Hypertension 2025 citations by CoLab: 0
Open Access
Open access
PDF
Effect of oral potassium supplementation on urinary potassium excretion and its diagnostic value for primary aldosteronism
Zhang K., Deng X., Li Z., Yi C., Kong J., Wang Y.
Q3
Taylor & Francis
Clinical and Experimental Hypertension 2025 citations by CoLab: 0
Open Access
Open access
PDF
Machine learning-based analyses of contributing factors for the development of hypertension: a comparative study
Tanaka M., Akiyama Y., Mori K., Hosaka I., Endo K., Ogawa T., Sato T., Suzuki T., Yano T., Ohnishi H., Hanawa N., Furuhashi M.
Q3
Taylor & Francis
Clinical and Experimental Hypertension 2025 citations by CoLab: 0
Open Access
Open access
PDF
Restoration of vascular dysfunction resulting from maternal high-fat diet via modulation of the NLRP3/IL-1β axis
Xiao Y., Bi X., Zhang R., Li Y., Sun W., Hao Y.
Q3
Taylor & Francis
Clinical and Experimental Hypertension 2024 citations by CoLab: 1
Open Access
Open access
PDF
Correction
Q3
Taylor & Francis
Clinical and Experimental Hypertension 2024 citations by CoLab: 0
Open Access
Open access
PDF
Uric acid mediates kidney tubular inflammation through the LDHA/ROS/NLRP3 pathway
Ouyang J., Wang H., Gan Y., Huang J.
Q3
Taylor & Francis
Clinical and Experimental Hypertension 2024 citations by CoLab: 0
Open Access
Open access
PDF
The association of schooling, sibling life situation, and dietary habits with the estimated 24-h urinary salt excretion and sodium-to-potassium ratio in 3-year-old children
Odani K., Yoshii K., Maruyama N., Takahata S., Kawazoe S., Miyawaki T., Higashi A.
Q3
Taylor & Francis
Clinical and Experimental Hypertension 2024 citations by CoLab: 0
Open Access
Open access
PDF
Gestational diabetes causes hyperactivity of the sympathetic nervous system and hypertension in adult mice offspring
Yang L., Zhu X., Zhu J., Hu Z., Wang C., Luo H., Bai X.
Q3
Taylor & Francis
Clinical and Experimental Hypertension 2024 citations by CoLab: 0
Open Access
Open access
PDF
Irisin mitigates salt-sensitive hypertension via regulating renal AMPK-Rac1 pathway
Mao J., Zhang X., Wang C., Peng S.
Q3
Taylor & Francis
Clinical and Experimental Hypertension 2024 citations by CoLab: 0
Open Access
Open access
PDF
Analysis of the current status and associated risk factors of cognitive function in Tibetan hypertensive patients at various altitudes
Yin L., Zhang X., Zhang H., Li R., Zeng J., Dong K., Wang Y., Li X.
Q3
Taylor & Francis
Clinical and Experimental Hypertension 2024 citations by CoLab: 1
Open Access
Open access
PDF
Causal relationship between gut microbiota, plasma metabolites, inflammatory cytokines and abdominal aortic aneurysm: a Mendelian randomization study
Li C., Liu Z., Yang S., Li W., Liang B., Chen H., Ye Y., Wang F., Liu X., Jiang Y., Wu H., Peng Y., Meng Z.
Q3
Taylor & Francis
Clinical and Experimental Hypertension 2024 citations by CoLab: 3
Open Access
Open access
PDF
Expression of TGF-β/Smad pathway-related indices in patients with isolated iliac artery aneurysms complicated with iliac arteriovenous fistula and their relationship with prognosis
Zhu Z., Yao Y., Shen G., Wang H.
Q3
Taylor & Francis
Clinical and Experimental Hypertension 2024 citations by CoLab: 0
Open Access
Open access
PDF

Top-100

Citing journals

10000
20000
30000
40000
50000
60000
Show all (70 more)
10000
20000
30000
40000
50000
60000

Citing publishers

50000
100000
150000
200000
250000
300000
350000
400000
450000
Show all (70 more)
50000
100000
150000
200000
250000
300000
350000
400000
450000

Publishing organizations

50
100
150
200
250
300
350
Show all (70 more)
50
100
150
200
250
300
350

Publishing organizations in 5 years

10
20
30
40
50
60
Show all (70 more)
10
20
30
40
50
60

Publishing countries

1000
2000
3000
4000
5000
6000
7000
8000
USA, 7949, 19.26%
Japan, 5014, 12.15%
China, 4162, 10.09%
United Kingdom, 2834, 6.87%
France, 2022, 4.9%
Italy, 1950, 4.73%
Germany, 1741, 4.22%
Netherlands, 1381, 3.35%
Canada, 1318, 3.19%
Sweden, 996, 2.41%
Brazil, 894, 2.17%
India, 879, 2.13%
Australia, 812, 1.97%
Spain, 784, 1.9%
Republic of Korea, 666, 1.61%
Poland, 534, 1.29%
Iran, 514, 1.25%
Belgium, 496, 1.2%
Switzerland, 465, 1.13%
Denmark, 459, 1.11%
Hungary, 401, 0.97%
Mexico, 331, 0.8%
Finland, 310, 0.75%
Turkey, 268, 0.65%
Israel, 263, 0.64%
Egypt, 257, 0.62%
Austria, 244, 0.59%
Argentina, 208, 0.5%
Ireland, 167, 0.4%
Russia, 144, 0.35%
Portugal, 137, 0.33%
Czech Republic, 123, 0.3%
Norway, 113, 0.27%
Saudi Arabia, 103, 0.25%
Greece, 93, 0.23%
Chile, 90, 0.22%
Malaysia, 73, 0.18%
Thailand, 64, 0.16%
Serbia, 61, 0.15%
New Zealand, 55, 0.13%
Singapore, 55, 0.13%
Croatia, 54, 0.13%
Slovakia, 51, 0.12%
Pakistan, 50, 0.12%
Czechoslovakia, 50, 0.12%
South Africa, 43, 0.1%
Yugoslavia, 42, 0.1%
UAE, 31, 0.08%
Kuwait, 30, 0.07%
Romania, 30, 0.07%
USSR, 30, 0.07%
Bulgaria, 27, 0.07%
Nigeria, 27, 0.07%
Cuba, 19, 0.05%
Lebanon, 19, 0.05%
Uruguay, 19, 0.05%
Ukraine, 18, 0.04%
Estonia, 18, 0.04%
Slovenia, 18, 0.04%
Venezuela, 17, 0.04%
Jordan, 15, 0.04%
Latvia, 15, 0.04%
Iraq, 14, 0.03%
Tunisia, 13, 0.03%
Bangladesh, 11, 0.03%
Colombia, 11, 0.03%
Algeria, 10, 0.02%
Vietnam, 9, 0.02%
Oman, 9, 0.02%
Qatar, 8, 0.02%
Ghana, 7, 0.02%
Trinidad and Tobago, 7, 0.02%
Bosnia and Herzegovina, 6, 0.01%
Georgia, 6, 0.01%
Lithuania, 6, 0.01%
Puerto Rico, 6, 0.01%
Indonesia, 5, 0.01%
Cyprus, 5, 0.01%
Sudan, 5, 0.01%
Montenegro, 5, 0.01%
Belarus, 4, 0.01%
Democratic Republic of the Congo, 4, 0.01%
Armenia, 3, 0.01%
Libya, 3, 0.01%
Morocco, 3, 0.01%
Kazakhstan, 2, 0%
Brunei, 2, 0%
Cameroon, 2, 0%
Costa Rica, 2, 0%
Luxembourg, 2, 0%
Mongolia, 2, 0%
Nepal, 2, 0%
El Salvador, 2, 0%
Kosovo, 2, 0%
Albania, 1, 0%
Afghanistan, 1, 0%
Burkina Faso, 1, 0%
Dominica, 1, 0%
Zimbabwe, 1, 0%
Yemen, 1, 0%
Show all (70 more)
1000
2000
3000
4000
5000
6000
7000
8000

Publishing countries in 5 years

200
400
600
800
1000
1200
1400
China, 1387, 39.23%
USA, 242, 6.84%
India, 234, 6.62%
Japan, 180, 5.09%
Iran, 174, 4.92%
Brazil, 109, 3.08%
Egypt, 88, 2.49%
Italy, 73, 2.06%
United Kingdom, 72, 2.04%
Republic of Korea, 69, 1.95%
Poland, 65, 1.84%
Germany, 62, 1.75%
Australia, 47, 1.33%
Saudi Arabia, 44, 1.24%
France, 41, 1.16%
Canada, 40, 1.13%
Mexico, 33, 0.93%
Spain, 32, 0.9%
Turkey, 31, 0.88%
Pakistan, 29, 0.82%
Malaysia, 24, 0.68%
Netherlands, 20, 0.57%
Thailand, 19, 0.54%
Russia, 18, 0.51%
Portugal, 18, 0.51%
Denmark, 18, 0.51%
Sweden, 18, 0.51%
Belgium, 12, 0.34%
UAE, 12, 0.34%
South Africa, 12, 0.34%
Argentina, 11, 0.31%
Finland, 11, 0.31%
Switzerland, 11, 0.31%
Austria, 10, 0.28%
Nigeria, 10, 0.28%
Czech Republic, 10, 0.28%
Iraq, 9, 0.25%
Ireland, 9, 0.25%
Bangladesh, 7, 0.2%
Greece, 7, 0.2%
Jordan, 7, 0.2%
Qatar, 7, 0.2%
Lebanon, 7, 0.2%
Slovakia, 7, 0.2%
Chile, 7, 0.2%
Hungary, 6, 0.17%
Romania, 6, 0.17%
Serbia, 6, 0.17%
Vietnam, 5, 0.14%
Israel, 5, 0.14%
Kuwait, 5, 0.14%
Georgia, 4, 0.11%
Indonesia, 4, 0.11%
Oman, 4, 0.11%
Singapore, 4, 0.11%
Cyprus, 3, 0.08%
Colombia, 3, 0.08%
New Zealand, 3, 0.08%
Croatia, 3, 0.08%
Democratic Republic of the Congo, 2, 0.06%
Mongolia, 2, 0.06%
Tunisia, 2, 0.06%
Ukraine, 1, 0.03%
Estonia, 1, 0.03%
Albania, 1, 0.03%
Algeria, 1, 0.03%
Armenia, 1, 0.03%
Bosnia and Herzegovina, 1, 0.03%
Cameroon, 1, 0.03%
Kenya, 1, 0.03%
Costa Rica, 1, 0.03%
Cuba, 1, 0.03%
Latvia, 1, 0.03%
Lithuania, 1, 0.03%
Malta, 1, 0.03%
Norway, 1, 0.03%
Slovenia, 1, 0.03%
Sudan, 1, 0.03%
Tajikistan, 1, 0.03%
Uzbekistan, 1, 0.03%
Uruguay, 1, 0.03%
Sri Lanka, 1, 0.03%
Show all (52 more)
200
400
600
800
1000
1200
1400